The Central government has given strict directions to draw a line between beauty products and medical interventions amid the booming market for skin-enhancing and anti-ageing procedures. The Centre clarified that cosmetic products cannot be injected into anyone’s body or promoted in the name of treatment.
In a public notice issued on May 18, the Central Drugs Standard Control Organisation (CDSCO) notified products supplied in injectable form do not qualify as cosmetics under the Drugs and Cosmetics Act,1940. The notice issued by Drugs Controller General of India Dr Rajeev Singh Raghuvanshi stated that,” No cosmetic is permitted to be used as injection by consumer/professionals/aesthetic clinics.”
The move has come into effect after growing popularity of injectable procedures offered by beauty clinics and cosmetics centres, including products marketed for skin brightening, anti-ageing and facial enhancement.
Dr. Kabir Sardana from the dermatology department of RMI hospital said many injectable cosmetic procedures use chemicals whose benefits are not scientifically proven, especially for conditions that often do not require injections. Referring to mesotherapy and injections promoted for melasma, he informed most are not approved by the US FDA and are being used off-label. He informed such procedures do have side effects while adding to patients financial burden.
CDSCO also flagged misleading advertisements and false claims that are done by the companies. It is punishable under the Drugs and Cosmetics Act and Cosmetics Rules, 2020.
Also Read: Hantavirus Outbreak On Cruise Ship: What Is HPS, Symptoms, WHO Risk Explained
-
-
-
-
